These two new “weight loss” drugs have been getting a lot of attention: Semaglutide, a GLP1 (glucagon like peptide 1) receptor agonist, and Tirzepatide, a dual GLP1, and GIP (glucose-dependent insulinotropic polypeptide) agonist. GLP1 and GIP are both peptides that...
Strategies to tackle stubborn fat loss, how the immune system gets involved, and more! In this week’s episode, Dr Elizabeth Yurth is back on the Biohacking Superhuman Performance podcast with Nathalie Niddam, talking about fat loss in particular for stubborn...
